Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Thromb Res ; 105(2): 103-8, 2002 Jan 15.
Article in English | MEDLINE | ID: mdl-11958799

ABSTRACT

OBJECTIVE: To compare the quality of oral anticoagulant therapy (QOAT), before and after referral of patients on oral anticoagulant therapy (OAT) from a hospital outpatient clinic (HOC) to general practitioners (GPs). DESIGN: Prospective observational study. Patients were identified by using the Laboratory Information System (LIS), containing all prescribed International Normalised Ratio of Prothrombin Time (INR) tests, from the HOC and GPs in the hospital submission area. SETTING: The HOC in a rural hospital, Aarhus County, Denmark (55,000 inhabitants), and GPs in the submission area. SUBJECTS: 124 OAT patients (59.7% males. Median age 70.0: 25-75 percentile: 62.0-76.0). MAIN OUTCOME MEASURE: The QOAT in terms of time spent within therapeutic INR interval (TI). The QOAT was compared 8 months before with 8 months after altering the monitoring organization. For patients monitored less than 8 months before the alteration, the QOAT was compared to a corresponding time period after the alteration. RESULTS: We identified 124 OAT patients, and found a significant increase in the QOAT from 65.0% before to 69.1% after referral of the patients to the GPs (P<.0001). In 75 patients with full follow-up, the QOAT increased from 67.5% before to 69.7% after the alteration (P<.0001). CONCLUSION: The results indicate that the QOAT in this geographical area is adequate, and that the quality performed by the GPs was at least as good as in the HOC. In order to document and increase the QOAT, continuous quality surveillance using the LIS has been initiated.


Subject(s)
Anticoagulants/therapeutic use , Family Practice/standards , Hospitals, Rural/standards , Outpatient Clinics, Hospital/standards , Quality of Health Care , Administration, Oral , Adult , Aged , Anticoagulants/adverse effects , Anticoagulants/standards , Denmark , Disease Management , Female , Hemorrhage/chemically induced , Humans , International Normalized Ratio , Male , Middle Aged , Prospective Studies , Prothrombin Time , Thromboembolism/drug therapy , Thromboembolism/prevention & control
SELECTION OF CITATIONS
SEARCH DETAIL
...